Brief: TheraVet Broadens Its BIOCERA-VET Product Line
22/11/2021 16:49
Nov 22 (Reuters) - THERAVET SA ALVET.PA :
* THERAVET BROADENS SIGNIFICANTLY ITS BIOCERA-VET® PRODUCT
LINE
THROUGH MAJOR DISTRIBUTION AND RESEARCH AGREEMENTS
* ADDITION OF TWO NEW COMPLEMENTARY LINES OF VETERINARY BONE
SUBSTITUTES TO BIOCERA-VET PORTFOLIO
* RESEARCH COLLABORATION ON NEW GENERATION PROPRIETARY BONE
SUBSTITUTES FOR VETERINARY APPLICATIONS
Source text for Eikon: ID:nBw5CM12fa
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Theravet SA
See all newsBrief: Theravet Announces Setting Up Of An Equity-Linked Financing Facility
Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
Brief: Theravet End-Dec Cash Position Of EUR 3.19 Mln
Brief: Theravet Signs New Distribution Agreement For Its Biocera-Vet With Elvetis